Windtree Therapeutics, Inc.(WINT)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-10-09 | Fraser Craig President and CEO | Purchase | +5,431 | +169.30%8,639 | $0.91 | $4,942 | View SEC filing | |
| 2023-09-28 | Fraser Craig President and CEO | Purchase | +2,500 | +4.51%57,880 | $1.02 | $2,550 | View SEC filing | |
| 2023-09-27 | Fraser Craig President and CEO | Purchase | +2,500 | +4.73%55,377 | $0.90 | $2,250 | View SEC filing | |
| 2023-04-27 | Fraser Craig President and CEO | Purchase | +1,497 | +27.15%7,010 | $1.77 | $2,650 | View SEC filing | |
| 2023-04-26 | Fraser Craig President and CEO | Purchase | +1,315 | +31.32%5,513 | $1.89 | $2,485 | View SEC filing | |
| 2022-07-27 | Fraser Craig President and CEO | Purchase | +2,500 | +1.12%226,558 | $0.38 | $950 | View SEC filing | |
| 2022-07-26 | Hamill John P. SVP & CFO | Purchase | +3,000 | +4.30%72,800 | $0.37 | $1,100 | View SEC filing | |
| 2022-07-26 | Fraser Craig President and CEO | Purchase | +2,500 | +1.13%224,058 | $0.37 | $935 | View SEC filing | |
| 2022-07-05 | Fraser Craig President and CEO | Purchase | +4,500 | +2.07%221,558 | $0.43 | $1,926 | View SEC filing | |
| 2022-06-30 | Fraser Craig President and CEO | Purchase | +7,000 | +3.33%217,058 | $0.42 | $2,908 | View SEC filing | |
| 2022-03-17 | Fraser Craig President and CEO | Purchase | +2,000 | +0.96%210,058 | $0.98 | $1,960 | View SEC filing | |
| 2022-03-15 | Simonson Steven SVP, Chief Medical Officer | Purchase | +5,000 | +6.36%83,602 | $1.00 | $4,999 | View SEC filing | |
| 2022-03-15 | Fraser Craig President and CEO | Purchase | +3,000 | +1.46%208,058 | $0.98 | $2,940 | View SEC filing | |
| 2022-01-10 | Center Laboratories, Inc. 10% Owner | Purchase | +1,349,432 | +119.55%2,478,176 | $1.77 | $2,382,538 | View SEC filing | |
| 2022-01-10 | Bioengine Capital Inc. 10% Owner | Mixed | -1,128,744 | -95.34%55,172 | $1.77 | $2,382,538 | View SEC filing | |
| 2021-11-22 | Fraser Craig President and CEO | Purchase | +930 | +2.50%38,158 | $1.60 | $1,488 | View SEC filing | |
| 2021-11-18 | Fraser Craig President and CEO | Purchase | +930 | +2.56%37,228 | $1.61 | $1,497 | View SEC filing | |
| 2021-10-25 | Fraser Craig President and CEO | Purchase | +3,000 | +9.01%36,298 | $1.90 | $5,700 | View SEC filing | |
| 2021-10-19 | Huang James Director | Purchase | +50,000 | +20.72%291,281 | $1.90 | $95,135 | View SEC filing | |
| 2021-10-19 | Fraser Craig President and CEO | Purchase | +3,000 | +9.90%33,298 | $1.91 | $5,730 | View SEC filing | |
| 2021-04-20 | Fraser Craig President and CEO | Purchase | +1,000 | +3.41%30,298 | $2.09 | $2,092 | View SEC filing | |
| 2021-04-19 | Hamill John P. SVP & CFO | Purchase | +1,000 | +40.00%3,500 | $2.07 | $2,067 | View SEC filing | |
| 2021-04-19 | Fraser Craig President and CEO | Purchase | +1,000 | +3.53%29,298 | $2.24 | $2,240 | View SEC filing | |
| 2021-04-08 | Curtis Eric SVP & COO | Purchase | +791 | +158.20%1,291 | $2.52 | $1,991 | View SEC filing | |
| 2021-04-07 | Fraser Craig President and CEO | Purchase | +500 | +1.80%28,298 | $2.57 | $1,285 | View SEC filing |
1-25 of 136